European Biotech Acquisition - Warrants (06/03/2026) Current Assets

As of the most recent data (December 2022), EBACW shows a current assets of $360K. That compares with $920K in the prior-year period — down 61.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBACW's current assets is now $360K (was $920K) — a 61.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.

Tracking EBACW's current assets over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $360K That compares with $920K in the prior-year period — down 61.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $360K) with ownership activity and broader fundamentals.